Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-09-29
1997-08-12
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, C07K 1464, A61K 3822
Patent
active
056565925
ABSTRACT:
Disclosed is a method of reducing pain in a mammal involving administration of relaxin to the mammal.
REFERENCES:
patent: 4656249 (1987-04-01), Tregear et al.
patent: 5145962 (1992-09-01), Hudson et al.
patent: 5179195 (1993-01-01), Hudson et al.
Horowitz, J.D. Am. J. Cardiology, vol. 70 Sep. 24, 1992 pp. 648-7113.
Prnewswire, Apr. 25, 1983, Abstract.
Genentech. Co. Report Oct. 14, 1987 Abstract.
Kakouris et al., Tips, vol. 181, 1306-1312 (1993).
Genentech, Inc. Anoul Report, 1992.
St. Louis et al., Life Science, vol. 37, pp. 1351-1357 (1985).
MacLennan, Scand. J. Rheumatol., Suppl. 88:7-15 (1991).
Ackland J.F. et al.; "Nonsteroidal Signals Originating in the Gonads"; Physiological Reviews; 72:731, 741-743 (1992).
Bryant-Greenwood G.D.; "At the Cutting Edge: The Human Relaxins: Consensus and Dissent"; Molecular and Cellular Endocrinology; 79:C125-C132 (1991).
Calguneri M. et al.; "Changes in Joint Laxity Occurring During Pregnancy"; Annals of the Rheumatic Diseases; 41:126-128 (1982).
Haley J. et al.; "Porcine Relaxin: Molecular Cloning and cDNA Structure"; DNA; 1:154-162 (1982).
Hudson P. et al; "Molecular Cloning and Characterization of cDNA Sequences Coding for Rat Relaxin"; Nature; 291:127-131 (1981).
Hudson P. et al; "Relaxin Gene Expression in Human Ovaries and the Predicted Structure of a Human Preprorelaxin by Analysis of cDNA Clones"; The EMBO Journal; 3:2333-2339 (1984).
Hudson P. et al.; "Structure of a Genomic Clone Encoding Biologically Active Human Relaxin"; Nature; 301:628-631 (1983).
Jones S.A. et al.; "Relaxin Increases Blood Pressure and Vasopressin Levels in Anaesthetized Rats"; Physiological Society; 37p (1986).
Kakouris H. et al.; "Relaxin: More Than Just a Hormone of Pregnancy"; Elservier Science Publishers Ltd. (UK); 14:4-6 (1993).
Kibblewhite D. et al.; "The Effect of Relaxin on Tissue Expansion"; Arch Otolaryngol Head Neck Surg; 118:153-156 (1992).
MacLennan A.H. et al.; "Serum Relaxin in Pregnancy"; The Lancet; 241-245 (1986).
Ostgaard et al.; "Prevalence of Back Pain in Pregnancy"; Spine; 16:549-552 (1991).
Ostgaard et al.; "Previous Back Pain and Risk of Developing Back Pain in a Future Pregnancy"; Spine; 16:432-436 (1991).
Saugstad L.F.; "Persistent Pelvic Pain and Pelvic Joint Instability"; European Journal of Obstetrics & Gynecology and Reproductive Biology; 41:197-201 (1991).
Sherwood C.D. et al.; "Purification and Characterization of Porcine Relaxin"; Academic Press, Inc.; 160:185-196 (1974).
St-Louis J. et al.; "Chronic Disease of Blood Pressure by Rat Relaxin in Spontaneously Hypertensive Rats"; Life Science; 37-1351-1357 (1985).
Walsh J.R. et al.; "Use of an Octadecylsilica Purification Method Minimizes Proteolysis During Isolation of Porcine and Rat Relaxins"; Endocrinology; 107:1258-1260 (1980).
Seed Brian
Seed John C.
Touzeau P. Lynn
Tsang Cecilia J.
LandOfFree
Use of relaxin as an analgesic and palliative for intractable pa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of relaxin as an analgesic and palliative for intractable pa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of relaxin as an analgesic and palliative for intractable pa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-160455